Diabetes :: GlaxoSmithKline statement in diabetes care study thiazolidinediones and heart failure
This is an analysis of existing data that has been previously published (online in Diabetes Care, 29 May 2007) and provides no new information on the risk of heart failure associated with the thiazolinediones (TZD) class.